Research Article
Survival and Cost-Effectiveness of Trabectedin Compared to Ifosfamide Monotherapy in Advanced Soft Tissue Sarcoma Patients
Table 4
Nontreatment-related costs per month during preprogression survival and postprogression survival.
| Nontreatment-related costs per month | Preprogression survival | Postprogression survival | Unit | Price | Source | Average use | Cost | Average use | Cost |
| Hospitalization per day | €494 | [7] | 0.21 | €106 | 0.48 | €236 | Full laboratory test | €43 | [10] | 1.02 | €44 | 1.24 | €54 | Haematological test | €18 | [10] | 0.16 | €3 | 0.13 | €2 | CT scan | €157 | [11] | 0.31 | €49 | 0.37 | €58 | MRI scan | €265 | [11] | 0.01 | €2 | 0.00 | €0 | Blood transfusion | €224 | [7] | 0.09 | €20 | 0.00 | €0 | General practitioner visit | €34 | [7] | 0.01 | €0 | 0.03 | €1 | Medical oncologist visit | €102 | [7] | 0.58 | €59 | 1.08 | €110 | Nurse | €34 | [7] | 0.01 | €0 | 0.02 | €1 | Psychologist | €82 | [7] | 0.01 | €1 | 0.00 | €0 | Total costs per period | | | | €284 | | €461 |
|
|